紀錄類型 : 書目-語言資料,印刷品: 單行本
其他作者 : Sharma, Chandra P.,
出版項 : Amsterdam :Academic Press,2022.
面頁冊數 : 1 online resource
內容註 : 1. Introduction<br>2. Characteristics and Immunobiology of COVID19<br>3. Molecular Mechanism and translation approaches<br>4. Inflammatory multisystem syndrome in COVID19: Insights on off-target organ system in susceptible and recovering population<br>5. Cytokine storm and stem cell activation in unveiling potential targets for diagnosis and therapy<br>6. Mesenchymal and hematopoietic stem cells: Novel avenues in combating COVID19<br>7. Immunomodulatory properties of mesenchymal and hematopoietic stem cells -- potential therapeutic target for COVID-19<br>8. COVID19 and acute myocardial injury: Stem cell driven tissue remodeling in COVID19 infection<br>9. Stem cell born signals and tissue regeneration in COVID19 infection<br>10. Stem cell transplantation COVID19 management: Translational possibilities and future<br>11. Therapeutic scale stem cell-derived exosomes for COVID -- 19: Models -- Validation, Management & Strategies<br>12. Therapy: present & future clinical perspective
標題 : Stem cells - Therapeutic use. -
標題 : COVID-19 (Disease) - Prevention. -
ISBN : 9780323886239
ISBN : 032388623X
LEADER 02142nam 22003251i 4500
001 49289
003 NhCcYBP
005 20221210140154.3
006 m d
007 cr |||||||||||
008 220303s2022 ne o 000 0 eng d
020 $a9780323886239$q(ePub ebook)
020 $a032388623X
020 $z9780323899727 (pbk.)
020 $z0323899722
035 $aebs3093780
037 $a9780323886239$bIngram Content Group
040 $aNhCcYBP$cNhCcYBP
041 $aeng
082 04$a616.02774$223
245 00$aStem cells and COVID-19 /$cedited by Chandra P. Sharma, Devendra K. Agrawal, Finosh G. Thankam.
264 1$aAmsterdam :$bAcademic Press,$c2022.
300 $a1 online resource
336 $atext$2rdacontent
337 $acomputer$2rdamedia
338 $aonline resource$2rdacarrier
505 0 $a1. Introduction<br>2. Characteristics and Immunobiology of COVID19<br>3. Molecular Mechanism and translation approaches<br>4. Inflammatory multisystem syndrome in COVID19: Insights on off-target organ system in susceptible and recovering population<br>5. Cytokine storm and stem cell activation in unveiling potential targets for diagnosis and therapy<br>6. Mesenchymal and hematopoietic stem cells: Novel avenues in combating COVID19<br>7. Immunomodulatory properties of mesenchymal and hematopoietic stem cells -- potential therapeutic target for COVID-19<br>8. COVID19 and acute myocardial injury: Stem cell driven tissue remodeling in COVID19 infection<br>9. Stem cell born signals and tissue regeneration in COVID19 infection<br>10. Stem cell transplantation COVID19 management: Translational possibilities and future<br>11. Therapeutic scale stem cell-derived exosomes for COVID -- 19: Models -- Validation, Management & Strategies<br>12. Therapy: present & future clinical perspective
533 $aElectronic reproduction.$bIpswich, MA$nAvailable via World Wide Web.
588 $aDescription based on CIP data; resource not viewed.
650 0$aStem cells$xTherapeutic use.$390978
650 0$aCOVID-19 (Disease)$xPrevention.$391645
700 1 $aSharma, Chandra P.,$eeditor.$1https://isni.org/isni/0000000033143746.$391646
700 1 $aAgrawal, Devendra K.,$eeditor.$1https://isni.org/isni/0000000033020850.$391647
700 1 $aThankam, Finosh G.,$eeditor.$391648
710 2 $aEBSCOhost$387894
776 08$iPrint version :$z9780323899727
856 40$uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=3093780$zClick to View (限總院院內)